Generating High-Resolution Synthetic CT from Lung MRI with Ultrashort Echo Times: Initial Evaluation in Cystic Fibrosis.


Journal

Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260

Informations de publication

Date de publication:
07 2023
Historique:
medline: 7 7 2023
pubmed: 5 7 2023
entrez: 5 7 2023
Statut: ppublish

Résumé

Background Lung MRI with ultrashort echo times (UTEs) enables high-resolution and radiation-free morphologic imaging; however, its image quality is still lower than that of CT. Purpose To assess the image quality and clinical applicability of synthetic CT images generated from UTE MRI by a generative adversarial network (GAN). Materials and Methods This retrospective study included patients with cystic fibrosis (CF) who underwent both UTE MRI and CT on the same day at one of six institutions between January 2018 and December 2022. The two-dimensional GAN algorithm was trained using paired MRI and CT sections and tested, along with an external data set. Image quality was assessed quantitatively by measuring apparent contrast-to-noise ratio, apparent signal-to-noise ratio, and overall noise and qualitatively by using visual scores for features including artifacts. Two readers evaluated CF-related structural abnormalities and used them to determine clinical Bhalla scores. Results The training, test, and external data sets comprised 82 patients with CF (mean age, 21 years ± 11 [SD]; 42 male), 28 patients (mean age, 18 years ± 11; 16 male), and 46 patients (mean age, 20 years ± 11; 24 male), respectively. In the test data set, the contrast-to-noise ratio of synthetic CT images (median, 303 [IQR, 221-382]) was higher than that of UTE MRI scans (median, 9.3 [IQR, 6.6-35];

Identifiants

pubmed: 37404152
doi: 10.1148/radiol.230052
doi:

Types de publication

Clinical Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e230052

Commentaires et corrections

Type : CommentIn

Auteurs

Arthur Longuefosse (A)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Julien Raoult (J)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Ilyes Benlala (I)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Baudouin Denis de Senneville (B)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Thomas Benkert (T)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Julie Macey (J)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Stéphanie Bui (S)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Patrick Berger (P)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Gilbert Ferretti (G)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Jean-Yves Gaubert (JY)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Renan Liberge (R)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Antoine Hutt (A)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Baptiste Morel (B)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

François Laurent (F)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Fabien Baldacci (F)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Gaël Dournes (G)

From the Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, Université Bordeaux Segalen, LaBRI, Mathematical Institute of Bordeaux (IMB), 146 rue Léo Saignat, 33076 Bordeaux, France (A.L., I.B., B.D.d.S., P.B., F.L., F.B., G.D.); CNRS, Bordeaux INP, LaBRI, UMR 5800, Bordeaux INP, UMR 5251, Talence, France (A.L., B.D.d.S., F.B.); CHU de Bordeaux, Service d'Imagerie Cardiovasculaire et Thoracique, Service des Maladies Respiratoires, Service d'Exploration Fonctionnelle Respiratoire, Centre de référence pédiatrique de la mucoviscidose, CIC 1401, Pessac, France (J.R., I.B., J.M., S.B., P.B., F.L., G.D.); INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Bordeaux, France (I.B., P.B., F.L., G.D.); MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany (T.B.); Department of Radiology, Grenoble-Alpes University Hospital, Grenoble, France (G.F.); Imaging Department, Hôpital La Timone, APHM, Aix Marseille University, Marseille, France (J.Y.G.); Department of Radiology, CHU Nantes, Nantes, France (R.L.); Department of Thoracic Imaging, Heart & Lung Institute, Lille, France (A.H.); and Pediatric Radiology Department, Clocheville Hospital, CHRU de Tours, Tours, France (B.M.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH